{"CAPTION FIG1.png": "'Figure 1: Flowchart for household contacts enrolled in the study, by seven acute respiratory syndrome coronavirus 2 \\\\(\\\\left\\\\{\\\\text{S4HS-CoV-2}\\\\right\\\\}\\\\) real-time reverse-traversing polymerase chain reaction (rRT-PCR) tasting results. \"Subset 4. \"Subset 6. \"Subset 7. \"Please see \"Analysis\" in the Methods for descriptions of the subjects.]\\n\\n'", "CAPTION FIG2.png": "'Figure 2: Caronavirus disease 2019 symptoms reported by household contacts (n = 4/7) on the date of first positive severe acute respiratory syndrome coronavirus 2 real-time reverse-transcription polymerase chain reaction (rHT-PCR) test compared to symptoms reported throughout the illness. Nasal congestion variable was present for 38 of 47 symptomaries (denominator = 38 for these estimates). \\\\({}^{\\\\circ}\\\\)Loss of smell: partial (n = 7 [50%]) and complete (n = 7 [50%]). \\\\({}^{\\\\circ}\\\\)Loss of taste: partial (n = 9 [64%]) and complete (n = 5 [36%]). \\\\({}^{\\\\circ}\\\\)Cough: dry (n = 12 [60%]) and productive (n = 8 [40%]). \\\\({}^{\\\\circ}\\\\)Subjective and objective.\\n\\n'", "CAPTION FIG3.png": "'Figure 3: Coronavirus disease 2019 symptoms reported by household contacts on the date of first positive severe acute respiratory syndrome coronavirus 2 real-time reverse-transcription polymerase chain reaction test, stratified by sex, age, underlying medical condition, and race [n = 4]. Constitutional: fewer, chills, muscle aches, fatigue. Upper respiratory: numpy nose, nasal compaction, sore throat. Lower respiratory: cough, discomfort in chest, shortness of breath, wheezing, chest pain. Neurologic: headache, loss of taste, loss of smell. Gastrointestinal: nausea, diarrhea, abdominal pain. Other sacs: American Indian/Alaska Native, Asian, other. _P_values were calculated using Fisher exact test.\\n\\n'", "CAPTION FIG4.png": "'Figure 4: Contributions of coronavirus disease 2019 symptoms reported by household contacts on the date of first positive severe acute respiratory syndrome coronavirus 2 real-time reverse-transcription polymerase chain reaction test (n = 47). Constitutional: fever, chills, muscle ashes, fatigue. Upper respiratory: urinary nose, nasal congestion, sore throat. Lower respiratory: cough, discomfort in chest, shortness of breath, wheezing, chest pain. Neurologic: headache, loss of taste, loss of smell. Gastrointestinal: nausea, diarrhea, abdominal pain.\\n\\n'", "CAPTION FIG5.png": "'Figure 5: Timeline of symptom onset in household contexts who changed from negative for severe acute respiratory syndrome coronavirus 2 (by real-time reverse-transcription polymerase chain reaction [PCRI] on day 0 to positive during follow-up individuals A\u2013E; in -S) and contacts who were asymptomatic at collection date of first positive specimen (individuals F\u2013K; in = 6) but developed symptoms later. \u201cFirst household exposure (defined as symptom onset in the household source case) to enrollment (day 0).\\n\\n'", "CAPTION TAB1.png": "'\\n\\n\\\\begin{table}\\n\\\\begin{tabular}{l l} \\\\hline \\\\hline \\\\multicolumn{1}{c}{} & \\\\multicolumn{1}{c}{} \\\\\\\\ \\\\multicolumn{1}{c}{} & \\\\multicolumn{1}\\n\\n'"}